Clinical trials
Phase 3 Mucopolysaccharidosis III trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aldagen | 1 |
| Ultragenyx Pharmaceutical Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis III | 2 |
| Adrenoleukodystrophy | 1 |
| Canavan Disease | 1 |
| Fucosidosis | 1 |
| Gangliosidosis, GM1 | 1 |
| Leukodystrophy, Globoid Cell | 1 |
| Leukodystrophy, Metachromatic | 1 |
| Lysosomal Storage Diseases | 1 |
| Metabolism, Inborn Errors | 1 |
| Mucolipidoses | 1 |
Trials
Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.